Journal of controlled release : official journal of the Controlled Release Society

Safe mRNA delivery and PCSK9 gene editing using natural-metabolite-based fatty acid lipids

Updated

Abstract

Agmatine-oleic acid (Agm-oa) lipid nanoparticles (LNPs) demonstrated a highly favorable safety profile with significantly lower serum LDH and IL-6 levels compared to benchmark formulations.

  • Agm-oa showed high mRNA encapsulation efficiency and robust in vitro transfection activity.
  • Electrostatic interactions and hydrogen bonding likely mediate strong mRNA association due to Agm-oa's guanidinium-containing headgroup.
  • Degradation of Agm-oa may release bioactive metabolites that suppress nitric oxide generation in macrophages while enhancing it in endothelial cells.
  • Agm-oa LNPs facilitated efficient on-target editing at the PCSK9 locus using an adenine base editor.
  • In hypercholesterolemic mice, Agm-oa LNPs effectively delivered mRNA and significantly reduced circulating LDL-C.
  • No detectable hepatotoxicity was observed after repeated administration of Agm-oa LNPs.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free